| dc.contributor.author | Choudhary, O.P. | |
| dc.contributor.author | Priyanka | |
| dc.contributor.author | Ahmed, J.Q. | |
| dc.contributor.author | Mohammed, T.A. | |
| dc.contributor.author | Singh, I. | |
| dc.contributor.author | Rodriguez-Morales, A.J. | |
| dc.date.accessioned | 2025-10-31T18:32:11Z | |
| dc.date.available | 2025-10-31T18:32:11Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12805/4505 | |
| dc.description.abstract | Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19. | en_US |
| dc.description.sponsorship | This study received no specific grants from any funding agency in the public, commercial, or not-for-profit sectors. All the authors acknowledge and thank their respective Universities and Institutes. | |
| dc.format | application/pdf | |
| dc.language.iso | eng | |
| dc.publisher | Taylor and Francis | |
| dc.relation.ispartof | urn:issn:2164-554X | |
| dc.rights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | SDG 3 | en_US |
| dc.subject | COVID-19, Its Impact, and Vaccination | en_US |
| dc.subject | Vaccine Efficacy and Immune Response in COVID-19 | en_US |
| dc.title | Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? | en_US |
| dc.type | https://purl.org/coar/resource_type/D97F-VB57 | |
| dc.identifier.doi | https://doi.org/10.1080/21645515.2021.2007015 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.05 | |
| dc.type.other | Commentary, Perspective u Opinion | |
| dc.identifier.journal | Human Vaccines and Immunotherapeutics | |
| dc.type.version | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |